Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20150721023282N18Phase 3Completed
Phase 3, randomised, open-label trial of pentoxifylline in decubitus ulcer (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Percent decrease in wound size and Complete wound healing. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20150721023282N18.